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Carriage of methicillin-resistant S. aureus and pseudintermedius, ESBL-producing or 
carbapenemase-producing Enterobacteriaceae in dogs with hypercortisolism 
 
The importance of antimicrobial resistant bacteria has increased significantly in small animal 
medicine. We investigated methicillin-resistant S. aureus and S. pseudintermedius, ESBL-
producing or carbapenemase-producing Enterobacteriaceae carriage in dogs with 
hypercortisolism (HC), which are considered immunocompromised and in healthy dogs. 
Based on our results, dogs with HC are at increased risk for carriage of ESBL-PE, and 
carriage rate seemed higher in HC dogs receiving a raw food diet. 
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Trägerschaft von methicillin-resistenten S. aureus und pseudintermedius, ESBL- oder 
Carbapenemase-produzierende Enterobacteriaceae bei Hunden mit Hyperkortisolismus  
 
Die Bedeutung antimikrobiell resistenter Bakterien hat in der Kleintiermedizin signifikant 
zugenommen. Wir haben die Trägerschaft von methicillin-resistenten S. aureus und S. 
pseudintermedius, ESBL- oder Carbapenemase-produzierende Enterobacteriaceae bei 
Hunden mit Hyperkortisolismus (HK), die als immunsuppremiert gelten, und bei gesunden 
Hunden untersucht. Basierend auf unseren Ergebnissen besteht für Hunde mit HK ein 
erhöhtes Risiko für eine Trägerschaft mit ESBL-PE, und diese schien bei Hunden mit HK, die 
eine Rohfleischfütterung erhielten, höher zu sein. 
 
Stichworte: Antibiotikaresistenz; Hund; Tupferproben; Cushing Syndrom 
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Abstract 
Background: The importance of antimicrobial resistant (AMR) bacteria has increased 
significantly in small animal medicine. AMR bacteria can represent a zoonotic risk for 
humans. Dogs with hypercortisolism (HC) are often immunocompromised, which could 
increase the risk of bacterial carriage or infection. So far, no studies have investigated carriage 
of methicillin-resistant Staphylococcus aureus (MRSA), methicillin-resistant Staphylococcus 
pseudintermedius (MRSP), extended-spectrum -lactamase-producing Enterobacteriaceae 
(ESBL-PE) and carbapenemase-producing Enterobacteriaceae (CPE) in dogs with HC. 
Objectives: To investigate MRSA, MRSP, ESBL-PE, CPE carriage in dogs with HC and in 
healthy dogs and to link raw food diet and hospitalization as potential risk factors. Animals: 
38 client-owned dogs with naturally occurring HC and 12 aged-matched client-owned healthy 
dogs. Methods: Prospective clinical study. Four swab samples from typical sites of carriage 
(nasal, pharyngeal, 2 rectal) were analyzed at the time of inclusion into the study and 1-3 
times thereafter. Swabs were cultured for the occurrence of MRSA, MRSP, ESBL-PE and/or 
CPE. Results: Four dogs with HC (10.5%), but none of the healthy dogs tested positive for 
carriage (rectal swabs) of ESBL-PE. There was a significant association of feeding a raw food 
diet and carriage of ESBL-PE in dogs with HC, but not in healthy dogs. Conclusion and 
clinical importance: This study gives evidence that dogs with HC are at increased risk for 
carriage of ESBL-PE. Feeding a raw food diet seemed to increase the ESBL-PE carriage rate 
in dogs with HC. More studies evaluating AMR bacteria carriage and infections in dogs with 
HC and healthy dogs are needed.   
 
 
  
9 
	
Introduction 
Companion animals are increasingly important in modern society and the human-animal-bond 
is more and more intense. This close contact between owner and animal leads to early 
recognition of health problems and early presentation of animals to veterinarians. Bacterial 
infections are common in companion animals and the use of antimicrobials is part of daily 
business in a small animal practice. Unfortunately, increased antibiotic use is one known 
factor in the development of antimicrobial resistant (AMR) bacteria.  
Methicillin-resistant Staphylococcus aureus (MRSA), Methicillin-resistant Staphylococcus 
pseudintermedius (MRSP), extended-spectrum -lactamase-producing Enterobacteriaceae 
(ESBL-PE) and, more recently, carbapenemase-producing Enterobacteriaceae (CPE) have 
emerged in both healthy and sick animals.1-8 
Transmission of these bacteria from infected or colonized companion animals to humans is a 
real threat and therefore a key public health concern.2,5-14  
Hypercortisolemia (naturally occurring or related to glucocorticoid therapy) induces a state of 
immunocompromise and increases susceptibility to various pathogens.15,16 Dogs receiving 
glucocorticoids were shown to have an increased risk for MRSP carriage.17 However, nothing 
is known about the risk of MRSP or other AMR bacteria carriage in dogs with naturally 
occurring hypercortisolism (HC). Feeding a raw food diet and prior hospitalization have been 
shown to increase the risk for MRSP and ESBL-PE carriage in dogs.17-19 Whether this holds 
true for dogs with naturally occurring HC is not known.  
Thus, the aim of the present study was to investigate the carriage rate of MRSA, MRSP, 
ESBL-PE and CPE in dogs with naturally occurring HC as well as that of healthy dogs. 
Furthermore, feeding a raw food diet and hospitalization were investigated as possible risk 
factors for MRSA, MRSP, ESBL-PE and CPE carriage. 
 
 
Materials and Methods 
Animals 
Client-owned dogs with naturally occurring HC were prospectively enrolled. Dogs were 
either included at the time of diagnosis of HC or during re-evaluation of trilostane therapy 
(Vetoryl®, Dechra, Europe). The diagnosis of HC was based on a combination of history, 
physical examination findings, haematology, serum biochemistry profile, urinalysis and 
positive endocrine testing (low-dose dexamethasone suppression test and/or ACTH 
10 
	
stimulation test).20 Dogs were excluded from the study if they had a history of antimicrobial 
therapy within two weeks prior to the time of enrolment. 
Healthy, aged-matched, client-owned dogs were enrolled as controls. The dogs were 
considered healthy, on the basis of detailed information provided by their owners and the 
results of a physical examination, haematology, and serum biochemistry profile.  
 
Experimental design 
The study was performed between October 2016 and February 2018 at our clinic. In order to 
evaluate carriage of MRSA, MRSP, ESBL-PE and/or CPE, sterile cotton swabs moistened 
with sterile saline were used to collect nasal (number of swabs/dog: 1), pharyngeal (1) and 
rectal samples (2). Swab sampling was performed at the time of inclusion (T0) in all dogs and 
if possible 1-3 times thereafter (T1-T3) in dogs with HC. Nasal swabs were collected by 
inserting the swabs 0.5 cm into the nostrils; pharyngeal swabs by swiping them across the 
pharyngeal region; and rectal swabs by inserting them 0.5-1 cm into the rectum. All swab 
samples were collected in the morning immediately after clinical examination of the dogs. 
During the initial examination, owners were questioned about prior hospitalisation (>24 
hours) and about the diet of their dogs over the previous 4 weeks. 
Dogs with newly diagnosed HC were started on trilostane therapy (starting dose 0.5-1 mg/kg 
q12h) after inclusion in the study. To monitor trilostane therapy, cortisol concentrations were 
measured twice, 1 hour apart, just before the morning trilostane dose (prepill 1 and prepill 2 
cortisol).21 Every dog undergoing trilostane therapy was assessed by standardized owner 
questionnaire and by clinical examination. The trilostane dose was adjusted according to the 
prepill cortisol concentrations and the clinical signs. 
 
 
Bacteriological analysis 
All swabs were placed in sterile plain tubes until processing. The nasal, and pharyngeal swabs 
and one rectal swab were pre-enriched in Mueller-Hinton Broth (Oxoid, Hampshire, UK) with 
6.5 % NaCl. Thereafter, 1ml was transferred to 9 ml Tryptic soy broth with cefoxitin 
(3.5mg/L) and aztreonam (75mg/L). After incubation at 37 °C for 16-20h, a total of 10 µl was 
transferred onto Brilliance MRSA 2 Agar (Oxoid, Hampshire, UK). Presumptive positive 
colonies were identified using matrix assisted laser desorption ionization time-of-flight mass 
spectrometry (MALDI-TOF MS; Bruker Daltonics, Bremen, Germany). The second rectal 
swab was pre-enriched in Enterobacteriaceae Enrichment broth (BD, Franklin Lakes, USA). 
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After incubation at 37 °C for 16-20 h, a total of 10 µl was transferred on Oxoid Brilliance™ 
ESBL Agar (Oxoid, Hampshire, UK), and onto chromID Carba Smart Agar (Bio Merieux, 
Marcy-l’Etoile, France). Presumptive positive colonies on Oxoid Brilliance™ ESBL Agar 
were verified for ESBL production with the colorimetric β LACTATM test kit (BioRad), 
according to the manufacturer's instructions. Presumptive positive colonies on chromID Carba 
Smart Agar were confirmed as Carbapenemase-producers by the NP Carba test (Bio Merieux, 
Marcy-l’Etoile, France), according to the manufacturer's instructions. 
 
Statistical Analysis 
Statistical analyses were performed using commercially available software (GraphPad 
Prism5, Graph Pad Software, San Diego, CA, USA). Differences in MRSA, MRSP, ESBL-
PE, CPE carriage were tested by means of the Fisher exact test. The level of significance was 
set at p < 0.05. 
 
 
Results 
Animals 
Thirty-eight dogs with HC were included in the study. Age ranged from 2.8-15.1 years 
(median, 10.6) and body weight from 2.9-38.8 kg (median, 8.9). Twenty-one dogs were male 
(11 castrated) and 17 were female (14 spayed). There were 31 pure-breed and 7 mixed-breed 
dogs. Twelve dogs were newly diagnosed with HC and 26 dogs were on trilostane therapy 
when included into the study.  
Twelve healthy dogs were included as a control group. Age ranged from 5.7-14 years 
(median, 8.1) and body weight from 7.5-44.5 kg (median, 22.1). Five dogs were male (4 
castrated) and 7 were female (5 spayed). There were 9 pure-breed and 3 mixed-breed dogs. 
 
Initial sampling 
Results of carriage of MRSA, MRSP, ESBL-PE, CPE of healthy dogs and dogs with HC at 
the time of enrolment are summarized in table 1.  
ESBL-producing Enterobacteriaceae were found in rectal swabs from four dogs with HC 
(10.5%; 1 newly diagnosed dog, 3 dogs on trilostane therapy (length of trilostane therapy: 1, 3 
and 19 months)).  
None of the healthy dogs showed carriage of MRSA, MRSP, ESBL-PE, CPE.  
12 
	
 
Sampling during follow-up in dogs with HC 
Results for MRSA, MRSP, ESBL-PE, CPE carriage in dogs with HC during follow up are 
summarized in table 2. Follow up sampling was performed between 1.6-8.8 months (median, 
4.5 months) (T1), 4.3-10.8 months (median, 7.5 months) (T2) and 9.6-15.6 months (median, 
13 months) (T3) after inclusion in the study, depending on the individual recheck time of each 
dog. 
None of the initially negative dogs tested positive for MRSA, MRSP, ESBL-PE, CPE carriage 
during the follow up period.  
One rectal follow-up swab sample from one initially positive dog was positive again for 
ESBL-PE after 10 months. The three remaining dogs, which were initially positive for ESBL-
PE at T0, tested negative throughout the entire follow up period (table 2). 
 
Raw food diet 
Out of the 38 dogs with HC, four dogs received a (partially or wholly) raw feed diet. Three of 
these dogs tested positive for ESBL-PE carriage.  
Of the 34 dogs, which did not receive raw feed diet, one tested positive for ESBL-PE 
carriage. There was a significant difference regarding feeding of a raw food diet and carriage 
of ESBL-PE in dogs with HC (p = 0.002). 
Two of the 12 healthy dogs received a partially raw feed diet and neither of them was positive 
for ESBL-PE. There was no significant difference in carriage of ESBL-PE in dogs with HC 
and healthy dogs receiving a raw food diet (p = 0.2). 
 
Hospitalization 
Of the 38 dogs with HC, 7 dogs were hospitalized ( 24 hours) within 1 month prior to 
inclusion in this study. One of these dogs tested positive for ESBL-PE carriage. There was no 
significant difference regarding hospitalization and carriage of ESBL-PE in dogs with HC (p 
= 1). None of the healthy dogs was hospitalized within 1 month prior to inclusion in this 
study. Therefore, no comparison with dogs with HC was possible. 
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Discussion  
 The main aim of this study was to investigate the carriage rate of MRSA, MRSP, 
ESBL-PE, CPE in dogs with HC compared with that of healthy dogs. Four dogs with HC 
(10.5%) tested positive for ESBL-PE. Although this was not statistically significant compared 
with the tested healthy dogs, the percentage of ESBL-PE carriage appears to be higher than 
that reported by a larger study with healthy dogs in our country (2.8%).22 Carriage rates < 
10% have been reported in Canada, United Kingdom, Switzerland, United States, Mexico and 
Algeria; carriage rates > 10 % have been reported in Portugal, Tunisia, France, Turkey and 
Kenya.22-32 This shows that carriage of ESBL-PE in dogs varies according to the world 
region. The carriage rate of ESBL-PE in HC dogs reported here seems higher than the values 
reported for healthy dogs in middle Europe and seems closer to the values reported from 
countries like Portugal, Tunisia and France. This gives evidence that dogs with HC are at 
increased risk for carriage of ESBL-PE. 
An association between glucocorticoid therapy and MRSP carriage has previously been 
described in dogs.17 Hypercortisolemia induces a state of immunocompromise and increases 
the susceptibility to various pathogens.15,16 In humans, the underlying cause of 
hypercortisolemia influences the risk for secondary infections. Patients developing 
hypercortisolemia from exogenous corticosteroids and patients with ectopic ACTH syndrome 
are more prone to developing infections compared to patients with endogenous 
hypercortisolism.16,33,34 The cause is not completely clear; however, higher cortisol levels in 
the blood of patients treated with exogenous corticosteroids or suffering from ectopic ACTH 
syndrome than in the blood of patients with endogenous hypercortisolism have been 
discussed.16,34 
One dog in this study with newly diagnosed HC had multiple skin lesions on its paws. One 
additional swab sample from the paws tested positive for MRSP and confirmed MRSP skin 
infection. It is important to distinguish between infection and carriage. Skin samples are 
known to have a higher MRSP prevalence than samples taken from the nose, pharynx and 
rectum.35 The main goal of this study was to determine the carriage rate of MRSA, MRSP, 
ESBL-PE, CPE in dogs with HC. The sampled sites (nose, pharynx, rectum) chosen are 
typical sites used to investigate carriage of MRSA, MRSP, ESBL-PE, CPE. Further studies 
evaluating skin infection or skin contamination with these bacteria in dogs with HC and 
evaluating the state of immunocompromise are therefore needed to completely evaluate the 
risk these patients pose for transmission among species.    
14 
	
As described previously, this study found an association between feeding and carriage 
of ESBL-PE in dogs with HC.18,19,36 A high prevalence of ESBL-PE in raw meat diets has 
been described.37,38 Farm animals, especially chickens, have been found to be a reservoir for 
ESBL-PE.39-41 It is suspected that the ingestion of raw meat contaminated with ESBL-PE 
results in the transfer of these bacteria to the animal. One dog carrying ESBL-PE at the time 
of inclusion and being fed raw food during the entire study period, was negative at the second 
sampling time point, but again positive at the third sampling time point. The most likely 
explanation for the negative culture results at the second sampling time point seems 
intermittent shedding. However, recarriage through contaminated raw food, other infected 
dogs or persons or contaminated surfaces in the household are other possible explanations.42 
We did not find CPE carriage in our study. However, looking at the so far low 
prevalence of CPE in companion animals reported by studies in middle Europe and at the 
rather low number of dogs included in this study, this is not surprising.4,43 Nevertheless, 
surveillance studies in companion animals are needed to supervise the spread of this 
hazardous pathogen.   
There are several limitations of this study. The first is the small number of dogs 
included. Another limitation is the inclusion of mainly treated dogs, which seemed well 
controlled (cortisol concentrations within the treatment target range). Whether inclusion of 
more newly diagnosed dogs with uncontrolled HC would have led to different results is 
unknown. A further limitation is that the state of immunocompromise was not assessed. To 
the authors’ knowledge, assessment of the state of immunocompromise in dogs with HC is 
lacking in the literature. Further studies are therefore needed to evaluate the immune status of 
dogs with HC before and during treatment, and to correlate these results with the risk of 
carriage or infection rate with MRSA, MRSP, ESBL-PE, CPE. 
 In conclusion, this study provides, to the best of our knowledge, the first information 
about the carriage rate of MRSP, MRSA, ESBL-PE and CP-CRE in dogs with HC. Overall, 
we showed that the prevalence of ESBL-PE in dogs with HC seems higher than so far 
reported in healthy dogs. Interestingly, raw meat feeding was significantly associated with 
carriage of ESBL-PE in dogs with HC. Further studies are needed comparing carriage and 
infections of MRSA, MRSP, ESBL-PE, CPE in dogs with HC and other diseases to evaluate 
the risk for MDR bacteria transmission between individuals.  
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Table 1: Prevalence of MRSA, MRSP, ESBL-PE and CPE carriage at inclusion 
 Dogs with HC Healthy dogs 
MRSP 0/38 0/12 
MRSA 0/38 0/12 
ESBL-PE 4/38 0/12 
CPE 0/38 0/12 
 
HC, hypercortisolism; MRSP, methicillin resistant Staphylococcus pseudintermedius; MRSA, 
methicillin resistant Staphylococcus aureus; ESBL-PE, extended-spectrum -lactamase-
producing Enterobacteriaceae; CPE, carbapenemase-producing Enterobacteriaceae 
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Table 2. Carriage of MRSA, MRSP, ESBL-PE, CPE in dogs with HC at inclusion and 
during follow up 
 Time T0 Time T1 Time T2 Time T3 
MRSP 0/38 0/19 0/11 0/5 
MRSA 0/38 0/19 0/11 0/5 
ESBL-PE 4/38 0/19 1/11 0/5 
CPE 0/38 0/19 0/11 0/5 
 
HC, hypercortisolism; MRSP, methicillin resistant Staphylococcus pseudintermedius; MRSA, 
methicillin resistant Staphylococcus aureus; ESBL-PE, extended-spectrum -lactamase-
producing Enterobacteriaceae; CPE, carbapenemase-producing Enterobacteriaceae 
T0: at inclusion; T1: 1.6-8.8 months after inclusion; T2: 4.3-10.8 months after inclusion; T3: 
9.6-15.6 months after inclusion.  
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